Forgot Password?
Return to Course Listing

CME: Tackling a sore subject: best practices in the identification and management of psoriatic arthritis (PsA)

Activity Description / Statement of Need:

In this online, self-learning activity:

Psoriatic arthritis (PsA) is a chronic, progressive disease that, untreated, may lead to permanent joint damage, disability, impaired quality of life, and cardiovascular disease. Both globally and in the U.S., the prevalence of PsA is 0.1% to 1%, but it is a common comorbidity of patients with psoriasis, affecting between a quarter and a half of those with moderate-to-severe disease. PsA is an immune-mediated disease characterized by inflammation of the skin and nails disease or a family history of psoriasis in association with pluralistic musculoskeletal disease that may involve entheses, the spine, and peripheral joints. Unlike the clinical manifestations of inflammatory, pathophysiological processes of psoriasis, a failure to intervene early in PsA with treatment often results in damage that is irreversible. In all, patients with PsA incur about four times the direct medical costs as compared to the average medical patient. Yet despite the considerable health and economic burden represented by the disease, delayed diagnosis and misdiagnosis are not uncommon.

Target Audience:

HCPs including: rheumatologists, dermatologists, and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in rheumatology and immunology; and any other HCPs with an interest in or who clinically encounter patients with PsA.

Commercial Support Disclosure: This program is supported by an educational grant from UCB. 

This activity is free of charge.

Release Date: June 22, 2024 -- Expiration Date: June 22, 2026

Faculty: Vivien Hsu, MD

Agenda

Faculty introduction, disclosures  

Introduction content: review of Psoriatic arthritis (PsA)

  • Epidemiology statistics; patient quality-of-life and economic impact 
  • Pathophysiology 
  • Clinical features and presentation: joint, nail, ocular, and other manifestations 
  • Differential diagnosis and diagnosis 
  • Common comorbidities, associated risks, and overall health burden 

Treatment of PsA 

  • Management overview, therapeutic goals, and general approach: treat-to-target with monitoring and consideration of treatment adjustment multiple times per year 
  • Treatment 
    • Patients with axial disease: approaches across the spectrum of severity 
      • Mild disease and NSAIDs 
      • Moderate-to-severe disease and the roles of: 
        • Tumor necrosis factor or IL-17 inhibitors 
        • Janus kinase (JAK) inhibitors 
        • Additional agents with narrow roles or conflicting evidence (e.g., IL-23 inhibitor, corticosteroids) 
    • Approaches to enthesitis, dactylitis 
    • More recent clinical evidence and guideline updates 
  • Challenges: treatment-emergent adverse effects, comorbidities, and patient satisfaction 
  • Patient case(s) 

Summary, conclusions, and best practice recap 

Learning Objectives

By the end of the session the participant will be able to:

  • Recall the comorbidity, risk factor, identification, and treatment-related healthcare burdens associated with PsA.
  • Identify the currently available and emerging pharmacotherapeutic treatments for management of PsA.
  • Formulate a treatment plan for a patient with PsA, including addressing comorbidities.

Accreditation

ACCME Activity #202792470

ScientiaCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME-MOC_badge

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABIM MOC Credit Type: Medical Knowledge

Physicians: For maintenance of certification (MOC) points, you must enter your board certification ID # and birth date correctly.  It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC points for this activity. By providing this data, you acknowledge that it will be shared with ACCME and the applicable certifying board. Please note: Not all activities on this site provide MOC points. If this activity does not specify that it provides MOC points in this section, then it does NOT provide MOC points. This activity provides MOC points only for ABIM.

Pharmacists

ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours  of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-0000-24-015-H01-P. This is an Application (A)-type activity. 

Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurses: The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit™ assigned by organizations accredited by the ACCME as satisfying Category 1 CME for National Commission on Certification of Physician Assistants (NCCPA) national certification maintenance. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCB) states that continuing education providers accredited by the ACCME may provide acceptable, accredited Advanced Practice Provider content. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.


Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.

Disclosures of Faculty: Vivien M. Hsu, MD, Professor of Medicine, Rutgers - RWJ Medical School, has no relevant financial disclosures. 

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures. 

Faculty WILL NOT discuss off-label uses of a commercial product. 

All relevant financial relationships have been mitigated. 

ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Support Disclosure: This program is supported by an educational grant from UCB. 

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

Additional Courses That Are Related To This Activity

Spotlight on actinic keratosis: updates in practice and treatment optimization

Recognition and management of epidermolysis bullosa: what the clinician needs to know

Advanced systemic mastocytosis: from recognition to treatment

How implicit bias and culture competence shape the patient healthcare experience